Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 10,977 | 15,009 | 14,651 | 12,092 | 15,290 |
| Cost of Goods | 5,804 | 8,068 | 7,771 | 5,403 | 6,088 |
| Gross Profit | 5,173 | 6,941 | 6,880 | 6,689 | 9,202 |
| Operating Expenses | 6,151 | 6,264 | 8,446 | 6,361 | 16,230 |
| Operating Income | -174 | 746 | -795 | 731 | -6,940 |
| Interest Expense | 74 | 98 | 100 | 96 | 51 |
| Other Income | 1,382 | 349 | 332 | 453 | 49 |
| Pre-tax Income | 1,133 | 997 | -562 | 1,089 | -6,943 |
| Income Tax | 542 | 609 | 169 | 528 | -200 |
| Net Income Continuous | 591 | 388 | -731 | 561 | -6,743 |
| Net Income | $591 | $388 | $-731 | $561 | $-6,743 |
| EPS Basic Total Ops | 0.28 | 0.21 | -0.42 | 0.42 | -4.76 |
| EPS Basic Continuous Ops | 0.32 | 0.23 | -0.44 | 0.39 | -4.80 |
| EPS Diluted Total Ops | 0.28 | 0.21 | -0.42 | 0.42 | -4.76 |
| EPS Diluted Continuous Ops | 0.32 | 0.23 | -0.44 | 0.39 | -4.80 |
| EBITDA(a) | $586 | $1,549 | $-30 | $1,190 | $-6,481 |